[1] AMIDON GL,HANS L,SHAH VP,et al.A theoretical basis for a biopharmaceutic drug classification:the correlation of in vitro drug product dissolution and in vivo bioavailability[J].Pharm Res,1995,12(3):413
[2] DOKOUMETZIDIS A,MACHERAS P.A century of dissolution research:from Noyes and Whitney to the biopharmaceutics classification system[J].Int J Pharm,2006,321(1-2):1
[3] 马锐,牛剑钊,张启明,等.药品检验中篮法和桨法溶出仪机械校验探讨[J].药物分析杂志,2016,36(5):873
MA R,NIU JZ,ZHANG QM,et al.Overview of mechanical qualification of basket and paddle dissolution apparatus in drug inspection[J].Chin J Pharm Anal,2016,36(5):873
[4] AZARMI S,ROA W,LOBENBERG R.Current perspectives in dissolution testing of conventional and novel dosage forms[J].Int J Pharm,2007,328(1):12
[5] 陈荣,黄斌,陈碧波,等.缓释制剂表征及其释放度检测技术研究进展[J].药物分析杂志,2016,36(11):1904
CHEN R,HUANG B,CHEN BB,et al.Research progress in detection techniques of in vitro release and characterization of sustained release preparations[J].Chin J Pharm Anal,2016,36(11):1904
[6] KHAMANGA SM,WALKER RB.Evaluation of rate of swelling and erosion of verapamil(VRP) sustained-release matrix tablets[J].Drug Deve Ind Pharm,2006,32(10):1139
[7] BRANCN RP,HUMBERTO GF.Bio-dis and the paddle dissolution apparatuses applied to the release characterization of ketoprofen from hypromellose matrices[J].AAPS PharmSciTech,2009,10(3):763
[8] 中华人民共和国药典2020 年版.四部[S].2020:134
ChP 2020.Vol Ⅳ[S].2020:134
[9] YU LX,WANG JT,HUSSAIN AS.Evaluation of USP apparatus 3 for dissolution testing of immediate-release products[J].AAPS PharmSciTech,2002,4(1):1
[10] BORST I,UGWU S,BECKETT AH.New and extended application for USP drug release apparatus 3[J].Dissolut Technol,1997,4(1):11
[11] NOORMOHAMMADI A,DODD RE,BECKETT AH,et al.Dissolution Testing Machine:America,5011662[P].1991-04-3 0
[12] JOSHI A,PUND S,NIVSARKAR M,et al.Dissolution test for sitespecific release isoniazid pellets in USP apparatus 3(reciprocating cylinder):optimization using response surface methodology[J].Eur J Pharm Biopharm,2008,69(2):769
[13] 宁保明,何兰,张启明,等.国内外溶出度试验用标准片的研究及应用[J].药物分析杂志,2012,32(8):1509
NING BM,HE L,ZHANG QM,et al.Overview and application of reference standard tablets for dissolution tester qualification[J].Chin J Pharm Anal,2012,32(8):1509
[14] SHOHIN IE,GREBENKIN DY,MALASHENKO EA,et al.A brief review of the FDA dissolution methods database[J].Dissolut Technol,2016,23(3):6
[15] 刘艳,张志鹏,索绪斌,等.缓控释制剂体外释放度的研究进展[J].时珍国医国药,2011,22(3):701
LIU Y,ZHANG ZP,SUO XB,et al.Research advances on in vitro release of sustained and controlled release preparations[J].Lishizhen Med Mater Med Res,2011,22(3):701
[16] 缪慧,阮昊,陈悦,等.生物相关性溶出度方法研究进展[J].中国现代应用药学,2018,35(1):138
MIAO H,RUAN H,CHEN Y,et al.Research advances of biorelevance dissolution method[J].Chin J Modern Appl Pharm,2018,35(1):138
[17] KOSTEWICZ ES,ABRAHAMSSON B,BERGSTRAND M,et al.In vitro models for the prediction of in vivo performance of oral dosage forms[J].Eur J Pharm Sci,2014,57:342
[18] RAMOS PB,GEORGES IM,DUTRA DM,et al.Applications of USP apparatus 3 in assessing the in vitro release of solid oral dosage forms[J].Br J Pharm Sci,2015,51(2):265
[19] MUDIE DM,AMIDON GL,AMIDON GE.Physiological parameters for oral delivery and in vitro testing[J].Mol Pharm,2010,7(5):1388
[20] 赵悦清,周仕海,柳文洁,等.口服固体制剂溶出方法建立和验证的技术探讨[J].药学学报,2018,53(2):202
ZHAO YQ,ZHOU SH,LIU WJ,et al.Discussion of development and validation of dissolution methods for solid oral dosage forms[J].Acta Pharm Sin,2018,53(2):202
[21] 付晓峰,柯学.口服药物溶出技术与体内外相关性的研究进展[J].药学与临床研究,2012,20(2):142
FU XF,KE X.Recent evolvement of oral drug dissolution technology and in vitro and in vivo correlation[J].Pharm Clin Res,2012,20(2):142
[22] CASTRO BKD,COSTA PE,MENDE CL,et al.Development of a dissolution method for gliclazide modified-release tablets using USP apparatus 3 with in vitro-in vivo correlation[J].Chem Pharm Bull,2018,66(7):701
[23] MISSAGHI S,FASSIHI R.Release characterization of dimenhydrinate from an eroding and swelling matrix:selection of appropriate dissolution apparatus[J].Int J Pharm,2005,293(1-2):35
[24] ROHRS BR,DARLENE L,WITT MJ,et al.USP dissolution apparatus 3(reciprocating cylinder):instrument parameter effects on drug release from sustained release formulations[J].J Pharm Sci,1995,84(8):922
[25] FDA.Drug Databases:Dissolution Methods[EB/OL].(2019-10-26)[2020-04-26] https://www.accessdata.fda.gov/scripts/cder/dissolution/index.cfm.
[26] KLEIN S,RUDOLPH MW,SKALSKY B,et al.Use of the BioDis to generate a physiologically relevant IVIVC[J].J Controlled Release,2008,130(3):216
[27] LI J,YANG L,FERGUSON SM,et al.In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES?) in multi-pH media using United States Pharmacopeia apparatus II and III[J].AAPS PharmSciTech,2002,3(4):59
[28] CHILUBA M,SANDILE MMK,RODERICK BW.Development and assessment of a USP apparatus 3 dissolution test method for sustained-release nevirapine matrix tablets[J].Dissolut Technol,2016,23(3):22
[29] KHAMANGA SMM,WALKER RB.The effects of buffer molarity,agitation rate,and mesh size on verapamil release from modifiedrelease mini-tablets using USP apparatus 3[J].Dissolut Technol,2007,14(2):19
[30] FOTAKI N,AIVALIOTIS A,BUTLER J,et al.A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations[J].Eur J Pharm Biopharm,2009,73(1):115
[31] RIBEIRO L,FERREIRA DC,VEIGA FJB.In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets[J].J Controlled Release,2005,103(2):325
[32] KLANAR U,MARKUN B,BAUMGARTNER S,et al.A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the correlation with the in vivo data[J].AAPS PharmSciTech,2013,15(1):267
[33] LUCIO MC,ALICE S,EDUARDO CP,et al.Development of USP apparatus 3 dissolution method with IVIVC for extended release tablets of metformin hydrochloride and development of a generic formulation[J].Chem Pharm Bull,2019,67(1):23
[34] MU X,TOBYN MJ,STANIFORTH JN.Development and evaluation of bio-dissolution systems capable of detecting the food effect on a polysaccharide-based matrix system[J].J Controlled Release,2003,93(3):309
[35] TOMOHIRO A,HIROYUKI K,ATSUSH K,et al.Prediction of the oral pharmacokinetics and food effects of gabapentin enacarbil extended-release tablets using biorelevant dissolution tests[J].Biol Pharm Bull,2018,41(11):1708
[36] KHANANGA SMM,WALKER R.In vitro dissolution kinetics of captopril from microspheres manufactured by solvent evaporation[J].Dissolut Technol,2012,19(1):42
[37] TRAPANI A,LAQUINTANA V,DENORA N,et al.Eudragit RS 100 microparticles containing 2-hydroxypropyl-β-cyclodextrin and glutathione:physicochemical characterization,drug release and transport studies[J].Eur J Pharm Sci,2007,30(1):64
[38] BRENDA E,FURLAN BF,OLIVEIRA PJM,et al.New approach for the application of USP apparatus 3 in dissolution tests:case studies of three antihypertensive immediate-release tablets[J].AAPS PharmSciTech,2018,19(7):2866
[39] CACACE J,REILLY EE,AMANN A.Comparison of the dissolution of metaxalone tablets(Skelaxin) using USP apparatus 2 and 3[J].AAPS PharmSciTech,2004,5(1):29
[40] NUNTHANID J,LUANGTANA AM,SRIAMORNSAK P,et al.Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery:effect of swelling on triggering in vitro drug release[J].Eur J Pharm Biopharm,2009,71(2):356
[41] WONG D,LARRABEE S,CLIFFORD K,et al.USP dissolution apparatus III(reciprocating cylinder) for screening of guar-based colonic delivery formulations[J].J Controlled Release,1997,47(2):173
[42] MONTERROZA D,PONCE DLL.Development of a USP apparatus 3 dissolution method for progesterone soft gelatin capsules[J/OL].Docin Library,2017[2020-04-26]http://www.docin.com/p-1945520734.html.
[43] JANTRATID E,JANSSEN N,CHOKSHI H,et al.Designing biorelevant dissolution tests for lipid formulations:Case example-Lipid suspension of RZ-50[J].Eur J Pharm Biopharm,2008,69(2):776
[44] KOBAYASHI M,SADA N,SUGAWAR M,et al.Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract[J].Int J Pharm,2001,221(1-2):87
[45] HE X,KADOMURA S,TAKEKUMA Y,et al.A new system for the prediction of drug absorption using a pH-controlled Caco-2 model:evaluation of pH-dependent soluble drug absorption and pH-related changes in absorption[J].J Pharm Sci,2004,93(1):71
[46] 王洋洋,黄聪,王彩君,等.基于平行人工膜渗透分析法对药物溶出/ 吸收仿生系统优化及其药物渗透性评价研究[J].药物评价研究,2019,42(8):1544
WANG YY,HUANG C,WANG CJ,et al.Optimization of DDASS based on PAMPA and drug permeability evaluation investigation[J].Drug Eval,2019,42(8):1544
[47] 徐雪芳,李超,王洋洋,等.药物溶出/ 吸收仿生系统法研究异欧前胡素溶出特征及与体内药代动力学相关性分析[J].锦州医科大学学报,2018,39(4):1
XU XF,LI C,WANG YY,et al.Study on dissolution characteristics of isoimperatorin using drug dissolution /absorption simulating system and its correlation analysis with pharmacokinetics[J].J Jinzhou Med Univ,2018,39(4):1
[48] 罗配,孙精通,王爱潮,等.单池药物溶出仿生系统考察卡马西平组合微丸的溶出特征[J].天津医科大学学报,2015,21(1):80
LUO P,SUN JT,WANG AC,et al.Dissolution of carbamazepine by single cell-DDASS[J].J Tianjin Med Univ,2015,21(1):80
